Micro and Nano 3D investigation of complex gut alterations-dementia interplay
Authors:
F. Palermo,
N. Marrocco,
L. Dacomo,
E. Grisafi,
M. Musella,
V. Moresi,
A. Sanna,
L. Massimi,
I. Bukreeva,
O. Junemann,
I. Viola,
M. Eckermann,
P. Cloetens,
T. Weitkamp,
G. Gigli,
G. Logroscino,
N. Kerlero de Rosbo,
C. Balducci,
A. Cedola
Abstract:
Alzheimer's disease (AD), a debilitating neurodegenerative disorder, remains one of the foremost public health challenges of our time. Despite decades of research, its etiology largely remains enigmatic. Recently, attention has turned to the gut-brain axis, a complex network of communication between the gastrointestinal tract and the brain, as a potential player in the pathogenesis of AD. Here we…
▽ More
Alzheimer's disease (AD), a debilitating neurodegenerative disorder, remains one of the foremost public health challenges of our time. Despite decades of research, its etiology largely remains enigmatic. Recently, attention has turned to the gut-brain axis, a complex network of communication between the gastrointestinal tract and the brain, as a potential player in the pathogenesis of AD. Here we exploited X-ray Phase Contrast Tomography to provide an in-depth analysis of the link between the gut condition and AD, exploring gut anatomy and structure in murine models. We conducted a comprehensive analysis by comparing the outcomes in various mouse models of cognitive impairment, including AD, frail mice, and frontotemporal dementia (FTD) affected mice. We discovered an association between substantial changes in the gut structure and the presence of amyloid-beta (A\b{eta}) in the brain. We found that the most important gut alterations are related to A\b{eta} occurrence in the brain. In particular, we investigated the gut morphology, the distribution of enteric micro-processes and neurons in the ileum. Understanding the intricate interplay between gut condition and dementia may open new avenues for early AD diagnosis and treatment offering hope for a future where these diseases may be more effectively addressed.
△ Less
Submitted 24 April, 2024; v1 submitted 25 January, 2024;
originally announced January 2024.
Immuno-Histo X-ray Phase Contrast Tomography: New 3D imaging technique for molecular tomography
Authors:
A. Quarta,
A. Sanna,
N. Pieroni,
B. Parodi,
F. Palermo,
I. Bukreeva,
M. Fratini,
L. Massimi,
D. Simeone,
X. Le Guével,
A. Bravin,
I. Viola,
E. Quintiero,
G. Gigli,
N. Kerlero de Rosbo,
L. Sancey,
A. Cedola
Abstract:
The still unmet ability of following the fate of specific cells or molecules within the whole body would give an outstanding breakthrough in the comprehension of disease mechanisms and in the monitoring of therapeutic approaches. Our idea is to push forward the bio-nanotechnology to a level where it serves the most advanced 3D bio-medical imaging to provide a multi-scale imaging ranging from the w…
▽ More
The still unmet ability of following the fate of specific cells or molecules within the whole body would give an outstanding breakthrough in the comprehension of disease mechanisms and in the monitoring of therapeutic approaches. Our idea is to push forward the bio-nanotechnology to a level where it serves the most advanced 3D bio-medical imaging to provide a multi-scale imaging ranging from the whole organ down to the cellular level, enabling high-resolution visualization of disease-relevant cells within the whole disease-altered biological context. We present here the first proof-of-concept of a novel tomography procedure, Immuno-Histo-X-ray Phase Contrast Tomography (XPCT) that combines cutting-edge XPCT, which provides detailed image of the whole organ, with molecular imaging at the cellular level, identifying the relevant cells via an immunohistochemistry-based approach. We combine metal nanoparticles and a single-domain antibody that target relevant cells. Our results lay the foundation for a new generation of 3D-bio-medical X-ray imaging.
△ Less
Submitted 6 June, 2023; v1 submitted 11 April, 2022;
originally announced April 2022.